EQUITY TRANSACTIONS

6 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

EQUITY TRANSACTIONS

EQUITY TRANSACTIONS

During the three and six months ended December 31, 2021 and 2020, respectively, stock options to purchase shares of the Company's common stock were exercised as follows:

	Three-Months Ended December 31,				Six-Months Ended December 31,
	2021		2020		2021		2020
Options exercised	—		18,000		—		68,531
Proceeds (in thousands)	$	—	$	86	$	—	$	311
Average exercise price per share	$	—	$	4.79	$	—	$	4.53

As of December 31, 2021, there was $0.8 million and $0.9 million of stock compensation expense related to non-vested options and non-vested restricted stock awards, respectively, which is expected to be recognized over weighted average periods of 2.68 years and 2.41 years, respectively.

On August 30, 2021, the Company closed its previously announced underwritten secondary offering of a total of 2,070,000 shares of its common stock at a public offering price of $8.65 per share, including the exercise in full by the underwriter of its option to purchase an additional 270,000 shares to cover over-allotments in connection with the offering. After the underwriting discount and offering expenses payable by the Company of $1.1 million, the Company received net proceeds of approximately $16.8 million.